
Glura M 50mg/500mg Tablet XR
Marketer
Comed Chemicals Ltd
Salt Composition
Sitagliptin (50mg) + Metformin (500mg)
Overview Glura M 50mg/500mg Tablet XR
Diabex Duo 50mg/500mg Extended-Release Tablets combine two medications to manage elevated blood glucose in patients with type 2 diabetes. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, and may lessen the risk of cardiovascular events. Diabex Duo may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and other medications. Taking it with food minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under your physician's guidance. Adherence to your prescribed diet and exercise regimen is crucial for diabetes control. Common side effects include diarrhea, nausea, vomiting, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential side effect, especially when combined with insulin or sulfonylureas; learn to recognize and manage this complication. This medication isn't appropriate for all individuals. Inform your doctor of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or excessive alcohol consumption before starting. Pregnant or lactating women should seek medical advice prior to use. Drug interactions are possible; disclose all medications to ensure treatment safety. Alcohol consumption should be limited due to its hypoglycemic effects. Your doctor will monitor your renal function and blood sugar levels throughout treatment.
Primary Ingredients of Glura M 50mg/500mg Tablet XR
No information provided. Please provide the text you wish me to rephrase.
Uses of Glura M 50mg/500mg Tablet XR
Managing type 2 diabetes
Major Benefits of Glura M 50mg/500mg Tablet XR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Glura M 50mg/500mg Extended-Release Tablets. Ingest the tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.
Common Side effects of Glura M 50mg/500mg Tablet XR:
- Decreased appetite
- Vomiting
- Upper respiratory tract infection
- Hypoglycemia (low blood glucose level)
- Abdominal bloating
- Nausea
- Diarrhea
How to use Glura M 50mg/500mg Tablet XR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glura M 50mg/500mg Extended-Release tablet whole; do not chew, crush, or divide it. Administer this medication with a meal.
How Glura M 50mg/500mg Tablet XR works:
Glura M 50mg/500mg Extended-Release tablets combine sitagliptin and metformin to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to improved glycemic control.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glura M 50mg/500mg extended-release tablets with alcohol is dangerous.
PregnancyCONSULT YOUR DOCTOR
Extended-release Glura M 50mg/500mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glura M 50mg/500mg tablets are likely not safe for use while breastfeeding. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Glura M 50mg/500mg XR tablets; dosage modification may be necessary. Consult your physician for guidance. Glura M 50mg/500mg XR tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverUNSAFE
Extended-release Glura M 50mg/500mg tablets are contraindicated for individuals with hepatic impairment and should be avoided. Medical advice is recommended.
What if you forget to take Glura M 50mg/500mg Tablet XR :
Should you forget to take a Glura M 50mg/500mg extended-release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glura M 50mg/500mg Tablet XR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
